Global gene expression analyses of hematopoietic stem cell-like cell lines with inducible Lhx2 expression by Richter, Karin et al.
BioMed  Central
Page 1 of 19
(page number not for citation purposes)
BMC Genomics
Open Access Research article
Global gene expression analyses of hematopoietic stem cell-like cell 
lines with inducible Lhx2 expression
Karin Richter†1, Valtteri Wirta†2, Lina Dahl1, Sara Bruce2,3, 
Joakim Lundeberg2, Leif Carlsson*1 and Cecilia Williams*2,3
Address: 1Umeå Center for Molecular Medicin, Umeå Universitet, 90187 Umeå, Sweden, 2School of Biotechnology, KTH, Royal Institute of 
Technology, AlbaNova University Center, 10691 Stockholm, Sweden and 3Department of Biosciences at Novum, Karolinska Institutet, 14157 
Huddinge, Sweden
Email: Karin Richter - karin.richter@ucmm.umu.se; Valtteri Wirta - valtteri@biotech.kth.se; Lina Dahl - lina.dahl@ucmm.umu.se; 
Sara Bruce - sara.bruce@biosci.ki.se; Joakim Lundeberg - joakim.lundeberg@biotech.kth.se; Leif Carlsson* - leif.carlsson@ucmm.umu.se; 
Cecilia Williams* - cecilia.williams@biosci.ki.se
* Corresponding authors    †Equal contributors
Abstract
Background: Expression of the LIM-homeobox gene Lhx2 in murine hematopoietic cells allows
for the generation of hematopoietic stem cell (HSC)-like cell lines. To address the molecular basis
of Lhx2 function, we generated HSC-like cell lines where Lhx2 expression is regulated by a tet-on
system and hence dependent on the presence of doxycyclin (dox). These cell lines efficiently down-
regulate Lhx2 expression upon dox withdrawal leading to a rapid differentiation into various
myeloid cell types.
Results: Global gene expression of these cell lines cultured in dox was compared to different time
points after dox withdrawal using microarray technology. We identified 267 differentially
expressed genes. The majority of the genes overlapping with HSC-specific databases were those
down-regulated after turning off Lhx2 expression and a majority of the genes overlapping with
those defined as late progenitor-specific genes were the up-regulated genes, suggesting that these
cell lines represent a relevant model system for normal HSCs also at the level of global gene
expression. Moreover, in situ hybridisations of several genes down-regulated after dox withdrawal
showed overlapping expression patterns with Lhx2  in various tissues during embryonic
development.
Conclusion: Global gene expression analysis of HSC-like cell lines with inducible Lhx2 expression
has identified genes putatively linked to self-renewal / differentiation of HSCs, and function of Lhx2
in organ development and stem / progenitor cells of non-hematopoietic origin.
Background
A small number of hematopoietic stem cells (HSCs) are
responsible for the continuous production of mature
blood cells throughout life. This process is based on the
capability of the HSC to replenish itself through a process
called self-renewal [1-3], and to differentiate into all
hematopoietic lineages. Consequently, analysis of the
mechanisms underlying HSC self-renewal and differentia-
tion is fundamental for understanding the maintenance
of the normal hematopoietic system. At present, our
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knowledge of these processes on the molecular and cellu-
lar level is limited, since studies on HSCs are hampered by
their low abundance in hematopoietic organs and are
thus difficult to access in sufficiently large quantities for
direct studies. An increase in the number of HSCs occurs
under normal physiological conditions in the liver during
embryonic development [4], indicating that the microen-
vironment in the fetal liver efficiently promotes self-
renewal of HSCs. Elucidation of the mechanisms respon-
sible for the expansion of the hematopoietic system dur-
ing embryonic development might therefore offer insights
into the mechanisms of self-renewal in the hematopoietic
system.
The expansion of the hematopoietic system is intimately
connected with the development of the liver, suggesting
over-lapping molecular mechanisms of these processes.
Liver development in the mouse is initiated at embryonic
day 8 (E8) when a distinct region of the ventral foregut
endoderm receives inductive signals from two adjacent
tissues, the septum transversum mesenchyme and the pre-
cardiac mesoderm [reviewed in [5]]. Ventral foregut endo-
dermal cells committed to hepatic fate proliferate and
form a liver bud from which hepatoblasts migrate and
intermingle with cells of the septum transversum mesen-
chyme. The mesenchymal cells originating from the sep-
tum transversum thereby contribute to the mesenchymal
part of the liver, and development into a functional organ
relies on continuous interactions between the mesenchy-
mal and endodermal portions of the liver [6-8]. At E10 the
liver has become a distinct organ with discernible lobes
and is infiltrated by numerous hematopoietic cells and
cells with HSC properties can be detected in the liver by
E11 [9].
Members of the LIM-homeodomain transcription factor
family play critical roles during embryonic development
in both vertebrates and invertebrates by controlling proc-
esses such as asymmetric cell division, tissue specification
and differentiation of specific cell types [reviewed in [10]].
One member of this family, Lhx2, is of particular interest,
based on its function in the development of several differ-
ent tissues via mesenchymal-epithelial interactions and
regulation of stem/progenitor cells [11-17]. Lhx2  is
expressed in the liver-associated septum transversum mes-
enchyme that becomes an integral part of the liver and its
expression is maintained during liver development until
adult stage in hepatic stellate cells [12,16]. Lhx2-/- embryos
display a decreased size of the liver manifested already at
E10.5, suggesting that Lhx2 is required for expansion of
the fetal liver [12,17]. The mutant phenotype is due to the
presence of activated hepatic stellate cells causing a
fibrotic and disorganized liver containing phenotypically
abnormal endodermal cells [12,16]. The mesenchymal
defect in the liver of Lhx2-/- mice cause a lethal anemia,
which is cell non-autonomous since the Lhx2-/- hemat-
opoietic cells appears to be normal [17], suggesting that
the mutant microenvironment is unable to support
hematopoietic development. These observations indicate
that Lhx2 expression in hepatic stellate cells is involved in
mesenchymal-epithelial cell interactions important for
liver expansion, organization, differentiation and forma-
tion of the hematopoietic microenvironment in the fetal
liver.
To further elucidate the putative role of Lhx2 in the
hematopoietic system we ectopically expressed Lhx2 in
hematopoietic progenitor/stem cells derived from embry-
onic stem (ES) cells differentiated in vitro and from adult
bone marrow (BM) cells. This approach allowed for the
generation of immortalized multipotent and Steel factor-
dependent hematopoietic progenitor cell (HPC) lines
[18,19]. The HPC lines share several characteristics with
normal HSCs such as response to specific cytokines/
growth factors, expression of transcription factors and
interactions with stromal cells [18,20]. The pattern of cell
surface markers expressed by HPC lines derived from ES
cells and adult BM is similar to that of early fetal and adult
HSCs, respectively. The HPC lines derived from adult BM
can generate erythroid, myeloid and lymphoid cells fol-
lowing transplantation into lethally irradiated recipients,
and can long-term engraft stem cell-deficient mice [19].
The cells engrafting the stem cell-deficient mice maintain
high level of expression of Lhx2 in vivo, which eventually
leads to a chronic myeloproliferative disorder resembling
human chronic myeloid leukemia [21]. Thus, ectopic
Lhx2 expression in hematopoietic cells allows for the gen-
eration of HSC-like cell lines, and molecular analyses of
these HSC-like cell lines would give information of the
role of Lhx2-induced self-renewal of HSCs, and hence
novel insights into stem cell physiology and pathology.
In order to elucidate the molecular basis of Lhx2-induced
self-renewal of HSCs we generated HSC-like cell lines
from ES cells differentiated in vitro with Lhx2 expression
controlled by a tetracycline-responsive element, and
hence dependent on the presence of the tetracycline-ana-
logue doxycyclin (dox) in the culture media [22]. These
dox-dependent hematopoietic progenitor cell (DoxHPC)
lines down-regulate Lhx2 expression almost two orders of
magnitude within 24 hrs after dox withdrawal, leading to
rapid differentiation into various myeloid cell types. We
used the DoxHPC lines to analyse Lhx2 function by com-
paring global gene expression in the presence of dox to
different time points after dox withdrawal using cDNA
array technology. This approach identified 267 genes dif-
ferentially expressed at all time points, and thus putatively
involved in Lhx2 function in stem cell self-renewal and /
or differentiation, and during organ development.BMC Genomics 2006, 7:75 http://www.biomedcentral.com/1471-2164/7/75
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Results
Generation of HPC lines from the ES cells with inducible 
Lhx2 expression
Previously, when generating HPC lines, we used ES cells
transduced with retroviral vectors containing Lhx2 cDNA
that were subsequently differentiated in vitro into embry-
oid bodies (EBs). The HPC lines were established by
expanding progenitor cells expressing Lhx2 present in col-
onies showing a distinct morphology that appeared in the
clonal assays of EB cells [18,23]. A similar approach was
used here, however, since we were unable to identify dis-
tinct colonies in the clonal assays containing dox (proba-
bly due to the efficient up-regulation of Lhx2 expression in
all cells), 96 colonies generated in the factor combination
supplemented with dox were randomly picked and
expanded individually in medium containing SF, IL-6 and
dox. Stable doxycyclin-dependent hematopoietic progen-
itor cell (DoxHPC) lines could be established from 66
Characterization of the DoxHPC lines Figure 1
Characterization of the DoxHPC lines. A. Real-time PCR analyses of Lhx2 expression in three independent DoxHPC 
lines at the indicated time points after dox withdrawal. Relative Lhx2 expression is compared to the expression in each 
DoxHPC lines in the presence of dox (Day 0) and this expression is arbitrarily set as 1. B. Flow cytometry analysis of GFP 
expression at the indicated time points after dox withdrawal in the DoxHPC line where GFP expression is linked to Lhx2 
expression by an ires. C. Cobblestone areas formed after seeding DoxHPC lines onto S17 stromal cells (upper panel) and 
maintenance of blast-like cells in these cultures (lower panel) in the presence of dox. D. Lack of cobblestone areas after seed-
ing DoxHPC lines onto S17 stromal cells (upper panel) and differentiation into macrophages (lower panel) in the absence of 
dox. E. May-Grünwald Giemsa staining of cytospun cells from a DoxHPC line cultured in the presence of dox (Day 0) as com-
pared to different time points after dox withdrawal.BMC Genomics 2006, 7:75 http://www.biomedcentral.com/1471-2164/7/75
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(69%) of these 96 colonies. The pattern of cell surface
marker expression was similar to that previously reported
for the HPC lines generated from day 6 EBs [18,23], e.g. c-
kit+/CD45+/CD41+/Sca-1-/Lin-  (data not shown). All
DoxHPC lines expressed Lhx2 and transcription of Lhx2
was efficiently down-regulated (>90%) within 24 hours
after dox withdrawal and was undetectable after 72 hours
(Figure 1A). In the DoxHPC7 line where GFP was linked
Overview of the microarray expression data Figure 2
Overview of the microarray expression data. A. Design of the experiment. This study includes 30 hybridizations using 
cDNA arrays (ArrayExpress accession numbers A-MEXP-175 and E-MEXP-431). Fourteen slides were allocated for profiling 
each of the DoxHPC1 and DoxHPC7 lines. Technical replicates were included at three different levels (replicated cell cultures 
of both cell lines, replicated hybridizations in each comparison using reciprocal dye assignments and repeated measurements 
using probes printed twice on each array). The hybridization scheme also includes two hybridizations between the two cul-
tures within each cell line, as well as two hybridizations between the different Lhx2-expressing cell lines. The 36, 72 and 96 
hours refer to the time after Lhx2 expression was down-regulated through withdrawal of dox from the culture medium. Each 
arrow denotes one hybridization. The tip and the base of the arrow indicate Cy5 and Cy3 assignments of the dyes, respec-
tively. Letter assignments by the arrows (A, B, C and D) are used to describe the comparisons in the text. Figure C, D and E 
show the MA-plots for the comparisons at 36 (A), 72 (B) and 96 hours (C) respectively. Figure B, F-H show the statistical sig-
nificance (1 - log of p-value) for each probe to be differentially expressed versus the M-value in a volcano-shaped plot; B 
between the cell lines DoxHPC1 and DoxHPC7 in E-comparison at time 0 hours and F-H corresponding values for the A-C 
comparison. Differentially expressed genes are shown in red. The feature corresponding to Lhx2 is indicated with an arrow.BMC Genomics 2006, 7:75 http://www.biomedcentral.com/1471-2164/7/75
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to Lhx2 expression, flow cytometry analyses revealed sim-
ilar instantaneous and efficient down-regulation of GFP
expression after dox withdrawal (Figure 1B). Rapid cellu-
lar changes appeared immediately after dox withdrawal
with respect to differentiation status and fraction of apop-
totic cells. The fraction of apoptotic cells increased from a
background level of 5% (cells in the presence of dox) to a
maximum of 35% five days after dox withdrawal. The frac-
tion of apoptotic cells decreased thereafter to background
level within ten days after dox withdrawal (data not
shown). Under these culture conditions (SF+IL-6 without
dox), differentiation into various myeloid cells such as
neutrophilic granulocytes, macrophages and megakaryo-
cytes, could usually be observed after 4–5 days (Figure
1E), with concomitant up-regulation of lineage specific
cell surface markers (data not shown). Although the dis-
tribution of the various myeloid cells differed between
different DoxHPC lines after dox withdrawal, all DoxHPC
lines maintained in SF+IL-6 without dox generated mast
cells and beyond eight days this cell type dominated the
cultures (Figure 1E). Immature hematopoietic progenitor
cells can functionally interact with stromal cells in vitro by
generating cobblestone areas [24] in long-term bone mar-
row culture) and are referred to as cobblestone area form-
ing cells (CAFCs) [25]. We have previously shown that the
HPC lines derived from ES cells differentiated in vitro effi-
ciently generated cobblestone areas when seeded onto
stromal cells [20]. The DoxHPC lines only formed cobble-
stone areas when seeded onto stromal cells in the pres-
ence of dox (Figure 1C), whereas rapid differentiation
into macrophages occurred in the absence of dox (Figure
1D). Thus, this is a reproducible and efficient system ame-
nable for global gene expression analyses comparing
Lhx2+ stem cells to their immediate Lhx2- progeny.
Analysis of gene expression changes caused by down-
regulation of Lhx2
We used cDNA microarray technology to investigate the
genome-wide transcriptional effects of down-regulation
of Lhx2 expression in the DoxHPC1 and DoxHPC7 lines.
Gene expression at 36, 72 and 96 hours after dox with-
drawal were analysed to elucidate differential gene expres-
sion early after Lhx2 down-regulation, but prior to the
time point when the majority of the cells are committed
myeloid cells. The hybridizations were carried out using
the design depicted in Figure 2A. The number of features
that remained on each array after filtering was high (82–
92%) and the majority of the excluded features were
removed by the first filtering step (i.e. GenePix and man-
ual flagging).
We used an empirical Bayes moderated t-test to identify
differential gene expression. Genes with a false-discovery
rate adjusted p-value lower than 0.01 were considered dif-
ferentially expressed. However, several of these showed
small fold-changes, and therefore only genes with an
absolute M-value higher than 0.4 (corresponds to a 1.3-
fold difference) were included in further analysis. The
results are summarized in Table 1, 2 and 3, and Figure 2
and 4A. Complete results are available as supplementary
data. Comparison of the two independent cultures within
each Lhx2-expressing cell line at time-point 0 (D-compar-
isons) indicated no differential expression (data not
shown). On the other hand, the comparison between
DoxHPC1 and DoxHPC7 lines (E-comparison) indicated
that a large number of genes differed in their expression
levels (Figure 2B). In total, 646 differentially expressed
array probes were identified (see Additional file 2), which
could be further divided into 265 probes (206 genes) with
higher expression in DoxHPC1 and 381 probes (295
genes) with higher expression in DoxHPC7. Interestingly,
the expression of Lhx2 is 2.7-fold higher in DoxHPC1 as
compared to DoxHPC7, which may at least partly explain
the difference between the cell lines. To identify genes dif-
ferentially expressed as a consequence of Lhx2 down-reg-
ulation, we combined the data for DoxHPC1 and
DoxHPC7 cell lines. This analysis revealed 463 probes
(365 genes) at 36 hours, 695 probes (525 genes) at 72
hours and 699 probes (528 genes) at 96 hours to be dif-
ferentially expressed (Figure 2C–H). A large proportion of
these genes were differentially expressed at all three time-
points (Figure 4A and Additional file 1). This shared set of
267 genes included 141 down-regulated and 126 up-reg-
ulated genes. The array data confirms the dox-dependent
regulation of Lhx2, as Lhx2 is the gene with the largest
decrease in expression (down by ~90%) after dox with-
Table 1: Number of array features and corresponding genes that are differentially expressed in the various comparisons. A false-
discovery rate of 0.01 is used, with and without a M-value cut-off of 0.4.
p < 0.01 (fdr) p < 0.01 (fdr) and |M| > 0.4
Comparison probes genes probes genes
A (36 vs. 0 h) 1718 1325 463 365
B (72 vs. 0 h) 2572 1936 695 525
C (96 vs. 0 h) 2562 1947 699 528
D (0 h vs. 0 h) 0 0 0 0
HPC1 vs. HPC7 (0 h) 2580 1995 646 498BMC Genomics 2006, 7:75 http://www.biomedcentral.com/1471-2164/7/75
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drawal (indicated by the arrows in Figure 2B–H). Agree-
ment in the M and p-values was observed in cases where
several independent probes represented different regions
of the same gene (data not shown), further validating the
accuracy of the method. Differential expression of 10
down-regulated and 10 up-regulated selected genes was
confirmed by using real-time PCR to compare gene
expression in the DoxHPC1 line in the presence of dox to
three days after dox withdrawal (Figure 3).
Twenty-six of the 337 probes that were differentially
expressed at all three time points were not included in
UniGene build 144. We used Blast sequence similarity
searches [26] to annotate the corresponding ESTs and the
results are provided in the (see Additional file 1). Several
of the unknowns map to either 5' or 3' UTRs, but also
partly to known genes such as Wbscr5, Map3k7, and
Eifay/Eifax. Also, one of the probes [GenBank:CX207886]
has no matches in any public sequence repository.
Whether these transcripts correspond to novel genes or
novel splice variants of already defined genes remains to
be determined.
Gene Ontology functional analysis of differentially 
expressed genes
We used the Gene Ontology classification of the 267 dif-
ferentially expressed genes for a two-step functional anal-
ysis to define the overall Gene Ontology category
representation and to identify themes that were over-rep-
resented compared to the complete mouse transcriptome
[27]. A Gene Ontology annotation was assigned to
approximately 50% of the 141 down-regulated and 126
up-regulated genes. Within the 'Biological processes'
branch of Gene Ontology, the largest groups that changed
their expression upon Lhx2 down-regulation were 'macro-
molecule metabolism' (20 down-regulated / 42 up-regu-
lated), 'signal transduction (19/20), 'cell growth and/or
maintenance' (18/19), 'nucleobase, nucleoside, nucle-
otide and nucleic acid metabolism' (18/17) and 'biosyn-
thesis' (8/20). A complete listing, which also includes the
'Molecular function' and 'Cellular component' branches
of the Gene Ontology classification, is available as Supple-
mentary data (see Additional file 3). The themes 'regula-
tion of signal transduction', 'organogenesis' and 'cell
death' were significantly over-represented among the
down-regulated genes (i.e. self-renewal-specific) (Table
4). Several metabolism-related genes were significantly
enriched among the up-regulated genes (i.e. differentia-
tion-specific), which was also evident when the data was
Table 2: The top 25 down-regulated genes in the DoxHPC lines after dox withdrawal. The columns 36 h, 72 h and 96 h refer to hours 
after dox withdrawal and include the M-values (=log2 [expression in differentiated/expression in undifferentiated]). The M-value of 
Lhx2 down-regulation is equivalent to a fold-change of approximately 8.
Symbol Gene name Genbank Unigene ID Gene ID 36 h 72 h 96 h
Lhx2 LIM homeobox protein 2 CX208629 Mm.142856 16870 -2.95 -2.71 -3.06
Serpina3g Serine (or cysteine) proteinase inhibitor, clade A, member 3G CX234493 Mm.264709 20715 -2.02 -2.41 -2.53
Bpgm 2,3-bisphosphoglycerate mutase CX200054 Mm.282863 12183 -1.63 -2.07 -2.06
Csrp2 Cysteine and glycine-rich protein 2 CX241650 Mm.2020 13008 -1.29 -1.28 -1.31
Plscr1 Phospholipid scramblase 1 CX230405 Mm.14627 22038 -1.21 -1.48 -1.64
Mal Myelin and lymphocyte protein, T-cell differentiation protein CX219564 Mm.39040 17153 -1.16 -1.14 -1.2
- Unknown CX220013 - - -1.13 -1.2 -1.1
Sdh1 Sorbitol dehydrogenase 1 CX204086 Mm.371580 20322 -1.1 -1 -1
Upp1 Uridine phosphorylase 1 CX218174 Mm.4610 22271 -1.09 -1.2 -1.33
Syne2 Synaptic nuclear envelope 2 CX218234 Mm.26652 319565 -1.02 -1.12 -1.12
Catnd2 DNA segment, KIST 4 CX237590 Mm.321648 18163 -1 -0.95 -1.02
Galnt2 UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-
acetylgalactosaminyl transferase 2
CX228653 Mm.33808 108148 -1 -1.1 -1.22
Etv5 Ets variant gene 5 CX240212 Mm.155708 104156 -0.99 -1.06 -1.16
Myo1b Myosin IB CX206461 Mm.3390 17912 -0.99 -1.17 -1.23
Parp8 RIKEN cDNA 5930433N17 gene CX230711 Mm.274466 52552 -0.96 -0.83 -0.66
Laptm4b Lysosomal-associated protein transmembrane 4B CX240664 Mm.197518 114128 -0.92 -0.91 -0.95
Nrgn Neurogranin CX240939 Mm.335065 64011 -0.91 -0.9 -1.18
B230104P22Rik RIKEN cDNA B230104P22 gene CX241478 Mm.25874 77976 -0.89 -0.98 -0.99
1810009M01Rik RIKEN cDNA 1810009M01 gene CX239344 Mm.28385 65963 -0.89 -0.93 -1.07
Sox4 SRY-box containing gene 4 CX240226 Mm.240627 20677 -0.88 -1.04 -1.06
2810408E11Rik RIKEN cDNA 2810408E11 gene CX242247 Mm.291015 106200 -0.86 -0.88 -0.97
Mfge8 Milk fat globule-EGF factor 8 protein CX239348 Mm.1451 17304 -0.86 -0.88 -1.01
Serpina3n Serine (or cysteine) proteinase inhibitor, clade A, member 3N CX200330 Mm.22650 20716 -0.86 -1.07 -1.15
Vim Vimentin CX235238 Mm.268000 22352 -0.85 -0.83 -0.81
Cklfsf4 Chemokine-like factor super family 4 CX206907 Mm.29658 97487 -0.85 -1.08 -1.16BMC Genomics 2006, 7:75 http://www.biomedcentral.com/1471-2164/7/75
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analysed using the KEGG metabolic pathways [28] (Table
4). Of note is that ten genes encoding components of the
glycolytic pathway, including a glucose transporter
(Slc2a3) and glycogen synthase, are among the genes up-
regulated after dox withdrawal (see Additional file 1 and
3), suggesting that this metabolic pathway is important
when stem cells are initiating differentiation.
Comparison with HSC gene expression signatures
Global gene expression in murine HSCs has previously
been studied using Affymetrix arrays [29,30]. Both studies
analysed the transcriptome of HSCs by comparing gene
expression in stem cell-enriched populations to that of
more differentiated cells (late progenitors and Lin-posi-
tive mature blood cells in Ivanova et al., and the main cell
population of the bone marrow in Ramalho-Santos et al.).
We compared the genes enriched in these HSCs popula-
tions to our list of differentially expressed genes (at Uni-
Gene transcript level 275 UniGene clusters correlated to
the previously defined 267 differentially expressed genes,
where 144 Unigene clusters were down-regulated and 131
were upregulated). In the comparison with the data from
Ivanova et al. (Signature 1 in Figure 4B), we divided their
dataset into two groups; "HSC and early progenitor-
enriched" (groups i-iv in Ivanova et al.) or "Late progeni-
tor and mature blood cell-enriched" (groups v-vii). Of our
differentially expressed Unigene transcripts 46 overlapped
with those in the "HSC and early progenitor-enriched"
transcripts and 25 overlapped with those in the "Late pro-
genitor and mature blood cell-enriched" transcripts (Fig-
ure 4B). A majority (30 or 65%) of the 46 Unigene
transcripts overlapping with the "HSC and early progeni-
tor-enriched" signature were down-regulated after dox
withdrawal, and a majority of the transcripts overlapping
with the late progenitors (20 genes or 80%) were up-reg-
ulated after dox withdrawal. The comparison between the
HSC-enriched transcripts from the study by Ramalho-San-
tos et al. (Signature 2 in Figure 4C) and our set of differen-
tially expressed transcripts showed an overlap of 57 genes.
Also in this comparison many transcripts (33, or 58%)
were found to be down-regulated after dox withdrawal
(Figure 4C). Thirteen genes were found in common
between all three studies (Smo, Tes, Upp1, Laptm4b,
Slco3a1, Fkbp1a, Itga6, A530057M15Rik,
6430596G11Rik, 1810009M01Rik, 1110004D19Rik,
D13Ertd275e, and AA536749).
Collectively these results show that Lhx2 expression partly
maintains the HSC signature and hence, the DoxHPC
lines with inducible Lhx2 expression is a relevant model
Table 3: The top 25 up-regulated genes in the DoxHPC lines after dox withdrawal. The columns 36 h, 72 h and 96 h refer to hours after 
dox withdrawal and include the M-values (=log2 [expression in differentiated/expression in undifferentiated]).
Symbol Gene name Genbank Unigene ID Gene ID 36 h 72 h 96 h
Slc2a3 Solute carrier family 2 (facilitated glucose transporter), member 3 CX234108 Mm.269857 20527 2.04 1.5 1
Bnip3 BCL2/adenovirus E1B 19kDa-interacting protein 1, NIP3 CX229381 Mm.2159 12176 1.8 1.69 1.53
Car2 Carbonic anhydrase 2 CX241425 Mm.1186 12349 1.49 1.25 1.07
Eno1 Enolase 1, alpha non-neuron CX240534 Mm.70666 13806 1.39 1.27 1.15
Aldoa Aldolase 1, A isoform CX237582 Mm.275831 11674 1.37 1.52 1.27
2410129H14Rik RIKEN cDNA 2410129H14 gene CX231735 Mm.38912 76789 1.36 1.19 1.05
Ndrg1 N-myc downstream regulated gene 1 CX218239 Mm.30837 17988 1.35 0.86 0.71
Ncf1 Neutrophil cytosolic factor 1 CX225706 Mm.4149 17969 1.3 1.48 1.62
- Unknown CX635138 - 1.29 1.49 1.64
Perp PERP, TP53 apoptosis effector CX231659 Mm.28209 64058 1.29 1.29 1.08
Pgk1 Phosphoglycerate kinase 1 CX242304 Mm.336205 18655 1.27 1.32 1.22
- Unknown CX207798 - - 1.19 1.16 1.1
- Unknown CX241476 - - 1.18 1.08 1.05
- Unknown CX200988 - - 1.18 1.09 1.06
Tpi1 Triosephosphate isomerase 1 CX242931 Mm.4222 21991 1.17 1.07 1.03
Unknown CX207886 - 1.15 0.98 0.84
Mcm10 Minichromosome maintenance deficient 10 (S. cerevisiae) CX214265 Mm.23828 70024 1.15 1.34 1.2
Txnip Thioredoxin interacting protein CX201093 Mm.271877 56338 1.14 1.32 1.15
P4ha1 Procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-
hydroxylase), alpha 1 polypeptide
CX231610 Mm.2212 18451 1.13 0.82 0.81
2610034M16Ri
k
RIKEN cDNA 2610034M16 gene CX201694 Mm.278512 69239 1.11 1.31 1.26
9830134C10Rik RIKEN cDNA 9830134C10 gene CX233114 Mm.328927 442827 1.1 1.43 1.37
2610034H20Rik RIKEN cDNA 2610034H20 gene CX225894 Mm.250541 76375 1.09 1.05 0.99
Ldh1 Lactate dehydrogenase 1, A chain CX239308 Mm.29324 16828 1.08 0.92 0.83
A830010M20Ri
k
RIKEN cDNA A830010M20 gene CX237601 Mm.261891 231570 1.07 1.19 1.02
Tec Cytoplasmic tyrosine kinase, Dscr28C related (Drosophila) CX228815 Mm.319581 21682 1.07 1 0.97BMC Genomics 2006, 7:75 http://www.biomedcentral.com/1471-2164/7/75
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system for normal HSCs also at the level of global gene
expression.
Genes most affected by Lhx2 expression
The fifty genes that show largest fold-change (up- or
down-regulated) after dox withdrawal are presented in
Table 2 and 3. The list of down-regulated genes contains
two members of the serpin family of protease inhibitors,
Serpina3g and Serpina3n, where the former is the most
highly differentially expressed gene. In general, serpins are
involved in diverse processes such as coagulation, extra
cellular matrix degradation, complement activation, fibri-
nolysis and apoptosis [31]. The expression pattern of
Serpina3n has not been well characterized, but expression
of Serpina3g is highly enriched in normal HSCs [32], and
in the hematopoietic precursor cell line FDCP-Mix [33].
The exact biological function of Serpina3g is not known,
but has been shown to involve inhibition of caspase-inde-
pendent cell death [34]. This is in agreement with the
observed increase in apoptosis after turning Lhx2 expres-
sion off, which is also reflected by the observation that
two pro-apoptotic genes, Bnip3  and  Perp  [35,36], are
among the 25 most up-regulated genes (Table 3). Over-
expression of Serpina3g in FDCP-Mix cells caused delay in
differentiation and increased clonogenic potential of
these cells [33], suggesting similar function in the Lhx2
expressing HPC lines and normal HSCs.
Most genes encoding enzymes within the glycolytic path-
way were up-regulated after Lhx2 expression was turned
off, but one highly differentially expressed gene within
this pathway, Bpgm  (2,3-bisphosphoglycerate mutase),
was an exception as it showed a decrease by 75%. This
enzyme is known to be present in erythrocytes where it is
involved in the reaction generating the metabolite 2,3-
bisphosphoglycerate, which is important for the oxygen-
hemoglobin interaction. However, Bpgm is also expressed
during early developmental stages (egg and pre-implanta-
tion stages) [37], suggesting that it may affect other cellu-
lar processes.
Genes linked to both normal and abnormal hematopoi-
etic progenitor cell function were identified among the
top 50 most differentially expressed genes. For example,
among the most down-regulated genes Sox4 and Plscr1
(Phospholipid scramblase 1), have both been reported to
be enriched in HSCs [29,30]. Although the normal func-
tion of Sox4 in HSCs is not known, over-expression of
Sox4 in mouse HSCs has recently been shown to cause
myeloid leukemia and Sox4 is also a frequent insertional
mutagenesis target in murine myeloid leukemias [38,39].
Plscr1-deficient mice have no major hematopoietic
defects, but Plscr1-/- hematopoietic progenitor cells show
decreased colony formation and impaired differentiation
to neutrophils in response to Steel factor and G-CSF [40].
Examples of the most up-regulated genes were Ndrg1 (N-
myc downstream regulated gene 1), and Ncf1 (Neutrophil
cytosolic factor 1). Up-regulation of these genes would be
expected since the DoxHPC lines under the culture condi-
tions used herein differentiate towards both neutrophil
and mast cell lineages, and these genes are linked to the
development and/or function of these cell types [41,42].
Etv5  and  Csrp2  (cysteine and glycine-rich protein 2),
which also showed significant decrease in expression after
Real-time PCR analyses confirm the cDNA array data Figure 3
Real-time PCR analyses confirm the cDNA array 
data. Expression analyses of 10 genes (including Lhx2) with 
down-regulated expression when Lhx2 expression is turned 
off (upper panel) and 10 genes with up-regulated expression 
when Lhx2 expression is turned off (lower panel). Relative 
expression of each gene is set as 1 when Lhx2 is expressed 
(Day 0) and is compared to the expression at day 3 after dox 
withdrawal.BMC Genomics 2006, 7:75 http://www.biomedcentral.com/1471-2164/7/75
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turning Lhx2 expression off, have been implicated in mes-
enchyme-epithelia interactions during embryogenesis
[43,44], similar to Lhx2. Interestingly, both Csrp2  and
Lhx2 are specifically expressed in hepatic stellate cells of
the liver [12,45]. Chronic liver injury causes activation of
hepatic stellate cells leading to hepatic fibrosis [46], and
both Lhx2 and Csrp2 have been negatively implicated in
this process [16,45], suggesting overlapping function of
these genes also in non-hematopoietic cells. In this
respect it is interesting to note that one of the top 25 up-
regulated genes is P4ha1 (proline-4-hydroxylase), which
encodes an enzyme important for post-translational mod-
ifications of collagen, leading to increased stability of col-
lagen fibrils. Expression of P4ha1 is also up-regulated in
the fibrotic Lhx2-/- fetal liver as compared to the normal
fetal liver [16]. Thus, analyses of differentially expressed
genes identified in this hematopoietic-based system
might also give insights into Lhx2 function (and lack of
function) in non-hematopoietic cells.
Overlapping gene expression patterns in mouse embryos 
of Lhx2 and genes down-regulated in DoxHPC lines upon 
dox removal
Lhx2 plays an important role during embryonic develop-
ment in the formation of several different tissues via mes-
enchymal-epithelial interactions and/or regulation of
stem/progenitor cells [11-17]. We therefore wanted to elu-
cidate whether any of the differentially expressed genes,
particularly genes that were down-regulated upon dox
withdrawal, also were expressed in tissues/organs where
Lhx2  is expressed during embryonic development.
Although we were comparing differential expression in
hematopoietic cells, 6 of 13 (46 %) of the genes down-
regulated after dox withdrawal that we have analysed thus
far, Nuak1, Tmem2, Etv5, Enc1, Csrp2, and Tgfb1i1 (Trans-
forming growth factor β1 induced transcript 4), showed
partly over-lapping expression pattern with Lhx2 in differ-
ent tissues. Lhx2 is expressed by cells in the liver, the hair
follicles, the developing cerebral cortex of the forebrain
and the olfactory epithelium, and examples of genes
showing overlapping gene expression with Lhx2 in two or
more of these tissues are shown in Figure 5. Tmem2 is
expressed in all four tissues, Nuak1 and Enc1 are expressed
in olfactory epithelium, hair follicles, cortex area of the
forebrain but not within the liver lobes, whereas Etv5 is
expressed hair follicles, cortex area of the forebrain,
weakly within the liver lobes but not in olfactory epithe-
lium (Figure 5). These results suggest that the mechanism
whereby Lhx2 immortalizes hematopoietic stem/progeni-
Table 4: The most regulated groups genes. Enriched biological processes (level 3), molecular function and chromosome distribution as 
defined by Gene Ontology and pathways as defined by Kegg of the differentially expressed genes.
Categorial system Differential Expression Term Genes p-value
Biological processes Down-regulated REGULATION OF SIGNAL TRANSDUCTION 4 0.015
ORGANOGENESIS 10 0.070
CELL DEATH 6 0.077
Up-regulated ALCOHOL METABOLISM 16 0.00000000000087
MACROMOLECULE METABOLISM 38 0.0000080
BIOSYNTHESIS 19 0.000086
CATABOLISM 16 0.00064
COENZYME AND PROSTHETIC GROUP METABOLISM 6 0.0028
VITAMIN METABOLISM 3 0.035
AMINE METABOLISM 5 0.063
Molecular function Down-regulated TRANSFERASE ACTIVITY, TRANSFERRING GLYCOSYL 
GROUPS
60 . 0 1 3
OXIDOREDUCTASE ACTIVITY, ACTING ON PEROXIDE 
AS ACCEPTOR
30 . 0 3 0
PROTEASE INHIBITOR ACTIVITY 4 0.087
Up-regulated CARBOHYDRATE KINASE ACTIVITY 3 0.0096
TRANSFERASE ACTIVITY, TRANSFERRING 
PHOSPHORUS-CONTAINING GROUPS
12 0.013
CARBON-OXYGEN LYASE ACTIVITY 3 0.054
PURINE NUCLEOTIDE BINDING 15 0.061
Chromosome Down-regulated 2 17 0.053
Up-regulated 8 12 0.021
Kegg pathways Up-regulated PENTOSE PHOSPHATE PATHWAY 6 0.0000029
GLYCOLYSIS / GLUCONEOGENESIS 10 0.00011
GALACTOSE METABOLISM 5 0.00018
FRUCTOSE AND MANNOSE METABOLISM 5 0.00061
CARBON FIXATION 4 0.0018
STARCH AND SUCROSE METABOLISM 4 0.026BMC Genomics 2006, 7:75 http://www.biomedcentral.com/1471-2164/7/75
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Comparisons between previously published stem cell signatures Figure 4
Comparisons between previously published stem cell signatures. A.Our study. Overlap between differentially 
expressed genes at 36, 72 and 96 hours after Lhx2 expression was down-regulated. The intersections between groups of differ-
entially expressed genes are visualized using Venn-diagrams (for clarity not drawn to proportions). The numbers refer to 
unique genes. B-C. Comparison between the transcripts differentially expressed in our study and two previously published 
hematopoietic stem cell-enriched gene expression signatures. Signature 1 (B) is derived from the [30] study and Signature 2 
(C) from the [29] study. Transcripts that are differentially expressed in our study at all three time-points are included. The 
overlapping transcripts are further split into transcripts that are up- and down-regulated in our study. Comparison between 
our data set and the two HSC signatures was carried out on the UniGene transcript level (UniGene build 147).BMC Genomics 2006, 7:75 http://www.biomedcentral.com/1471-2164/7/75
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Gene expression analyses in mouse embryos of genes with down-regulated expression when Lhx2 expression is turned off Figure 5
Gene expression analyses in mouse embryos of genes with down-regulated expression when Lhx2 expression is 
turned off. In situ hybridization using probes of the indicated genes on sagital sections on E12.5-13.5 embryos of the indicated 
tissues. The border between the olfactory epithelium and the underlying mesenchyme is outlined in each section by a broken 
line. Examples of individual hair (whisker) follicles are indicated by arrows in each section. The part of the developing forebrain 
that gives rise to the cerebral cortex is indicated by ctx in each section. Arrowheads indicate the border between individual 
liver lobes in each section. Scale bars sections of Olfactory epithelium, Hair follicles and Liver; 100 µm, Fore brain; 200 µm.BMC Genomics 2006, 7:75 http://www.biomedcentral.com/1471-2164/7/75
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tor cells might partly overlap with the function of Lhx2 in
the development of a variety of organs.
Discussion
We have generated HSC-like cell lines by differentiating
ES cells with inducible Lhx2  expression  in vitro. Self-
renewal of these DoxHPC lines, is strictly dependent on
Lhx2 expression, since down-regulation of Lhx2 expres-
sion leads to loss of CAFCs and rapid and efficient differ-
entiation into a variety of myeloid cells. To elucidate the
putative function of Lhx2 in stem cells, we used microar-
ray technology to compare global gene expression in these
cell lines in the presence of dox (Lhx2 expression on) to
different time points after dox withdrawal (Lhx2 expres-
sion off). We identified 267 genes (141 down-regulated
and 126 up-regulated) that showed differential expression
at all time points (36, 72 and 96 hours) after Lhx2 expres-
sion was turned off. Gene Ontology classification revealed
that genes related to 'regulation of signal transduction',
'organogenesis' and 'cell death' were over-represented
among the down-regulated genes (i.e. "stem cell-spe-
cific"), and that metabolism-related genes were over-rep-
resented among the up-regulated genes (i.e.
"differentiation specific").
We have previously shown that the HPC lines generated
by Lhx2 expression resemble normal HSCs in many basic
molecular, cellular and biochemical aspects [18-
20,23,47]. Moreover, the HPC lines derived from bone
marrow that engrafted stem cell-deficient mice main-
tained Lhx2 expression in vivo and caused myeloprolifera-
tion [21]. We therefore anticipated identifying genes
involved in both physiological and pathological processes
affecting HSCs by analyses of global gene expression of
the DoxHPC lines. A comparison of the differentially
expressed genes to previously defined HSC gene expres-
sion signatures revealed that a majority of the overlapping
genes expressed in HSC-containing populations were
those down-regulated after Lhx2 expression was turned
off. Thus, although we have used a different microarray
platform, the genes defined as stem cell-specific in our sys-
tem (e.g. the 144 Unigene clusters that belonged to group
of genes down-regulated after dox withdrawal), reveal a
21 and 23 % overlap with genes defined as HSC-specific
in the two different stem cell databases, respectively (see
Additional file 4). Furthermore, thirteen of the 144 Uni-
gene clusters (9 %) defined as stem cell-specific in our
study overlapped with both HSC databases (see Addi-
tional file 4). In interpreting the results from the compar-
ison between our stem cell-specific genes and the HSC-
enriched genes in Ivanova et al. [30] and Ramalho-Santos
et al. [29], it should be noted that the probes on the arrays
in those studies only has an overlap in our array of 50 and
57%, respectively. The overlap from our model system for
HSCs could be further viewed in relation to a study show-
ing that the overlap between three different HSC-specific
datasets varied between 19 and 32 % [48]. It should be
noted that, despite the fact that these studies were carried
out using the same Affymetrix GeneChips, identical anal-
ysis approaches and essentially the same cell populations,
there is still considerable variability between the different
HSC-specific datasets. Moreover, a majority of the genes
that were up-regulated after Lhx2 expression was turned
off were preferentially expressed in differentiated cell pop-
ulations. These results suggest that there is molecular
overlap in the self-renewal and differentiation process
between the DoxHPC lines and normal HSCs also at glo-
bal gene expression level. We could also identify genes
linked to malignant transformation of hematopoietic
cells and one such example is Sox4, which was recently
shown to cause acute leukemia if over-expressed in HSCs
[38]. Sox4 has also been identified as a frequent inser-
tional mutagenesis target in murine myeloid leukemias
[39], further supporting a role of this gene in malignant
transformation. Since Lhx2 is always integrated into the
same position, close to the Hprt1 gene in the DoxHPC
lines, expression of insertional mutagenesis target genes is
not due to insertional mutation, as has been suggested for
retroviral integration [49], hence, these genes are more
likely to be linked to Lhx2 function and/or stem cell func-
tion. Human chronic myeloid leukemia cells have been
reported to express Lhx2 although its function in the dis-
ease is not clear [50]. Another gene down-regulated after
Lhx2 expression is turned off is Prkd2 (Protein kinase D2,
see Additional file 1), which has also been shown to be a
substrate for the BCR-ABL fusion protein present in
chronic myeloid leukemia cells [51]. These results reveal a
putative functional link between Lhx2 and the BCR-ABL
fusion protein. However, both Sox4 and Prkd2 have been
shown to be preferentially expressed in HSCs [29,30],
which suggests overlapping molecular mechanism regu-
lating both HSC physiology and pathology. By using our
inducible system it would be possible to dissect these
processes on the molecular, cellular and biochemical
level.
It has been suggested that the Notch pathway and path-
ways activated by different morphogens such as Wnt,
Bone morphogenetic proteins (BMP) and hedgehog, are
important regulators of stem cell function [52-55]. We
have previously shown that the Lhx2-induced HPC lines
self-renew by a cell nonautonomous mechanism [20],
and the anemia in Lhx2-/- mouse embryos is due to a cell
nonautonomous mechanism, suggesting that Lhx2 regu-
lates genes encoding proteins involved in cell-cell interac-
tions [17]. However, we have not found any evidence for
differential expression of major mediators of the Notch or
Wnt pathways in the DoxHPC lines after turning Lhx2
expression off. Although the microarrays we used do not
contain all mediators of these pathways, the results sug-BMC Genomics 2006, 7:75 http://www.biomedcentral.com/1471-2164/7/75
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gest that the mechanism whereby Lhx2 expression gener-
ates HPC lines is partly or completely independent of at
least the Wnt and Notch pathways. We did find consistent
down-regulated expression of the hedgehog receptor Smo
(Smoothened) after Lhx2 expression was turned off (see
Additional file 1), and Smo has also been shown to be
preferentially expressed in normal HSCs (see Additional
file 4) [29,30]. However, expression of the ligands (Sonic,
Indian and Desert hedgehog) was very low to undetecta-
ble by real-time PCR analyses of the cell lines (data not
shown). Thus, the functional role, if any, of hedgehog sig-
nalling in these cells remains to be determined. Further-
more,  Tsg  (Twisted gastrulation), which is a soluble
modulator of BMP-signalling, was identified among the
genes down-regulated after Lhx2 expression was turned off
(see Additional file 1), and is also defined as an HSC-spe-
cific gene (see Additional file 4) [29,30]. The functional
relevance of this observation remains to be determined as
Tsg protein has been show to act as a BMP antagonist as
well as a BMP agonist [56,57].
Lhx2 appears to play an important role during embryonic
development in the formation of several different tissues
via mesenchymal-epithelial interactions and/or regula-
tion of stem/progenitor cells [11-17]. One of our aims was
therefore to identify gene(s) directly or indirectly regu-
lated by Lhx2, possibly providing insights into the func-
tion of Lhx2  in these processes. A caveat to this
assumption is that it is not known whether Lhx2 functions
as a transcriptional activator, repressor, or both. The only
reported target genes putatively regulated by Lhx2  in a
direct manner are those encoding olfactory receptors [58]
and these receptors are not expressed in Lhx2-/- olfactory
epithelia [11,13]. These observations suggest that genes
activated by Lhx2 are down-regulated in Lhx2-/- animals,
and conversely, genes repressed by Lhx2 are up-regulated
in Lhx2-/- animals. A putative example of the latter is P4ha1
as this gene was up-regulated after Lhx2 is turned off in
DoxHPC lines, and the expression of this gene was also
up-regulated in the liver of Lhx2-/- embryos compared to
wild type embryos [16]. Although our analysis was made
in hematopoietic cells, almost 50% of the genes analysed
among those down-regulated after dox withdrawal (Lhx2
expression turned off), showed similar expression pattern
as Lhx2 in different non-hematopoietic organs/cells dur-
ing embryonic development. Preliminary data suggests,
however, that several of these genes show maintained
expression pattern in Lhx2-/-  embryos, suggesting that
these genes are not direct transcriptional targets for Lhx2.
A plausible explanation for this observation is that differ-
ent genes exert their function via parallel pathways in the
regulation, formation or differentiation of a certain tissue
but are not dependent on each other for their expression
in that particular tissue. An illustrative example of such
parallel but equally important pathways during organ for-
mation can be observed during eye development, where
both Lhx2 and Pax6 null mutant (Sey) embryos show a
developmental arrest at the optic vesicle stage [17,59].
However, the expression of these genes appear to be inde-
pendent of each other since Pax6  isexpressed in the
arrested optic vesicle in the Lhx2-/- embryos and Lhx2 is
expressed in the arrested optic vesicle in Pax6-/- embryos
[17]. Whether the genes identified in this study play an
equally important role as Lhx2 in the development of the
respective organ remains to be determined. Our approach
may therefore have identified both genes that are directly
or indirectly regulated by Lhx2, and genes that play an
important role together with Lhx2 via parallel pathways
but are independent of Lhx2 expression, similar to the
Lhx2/Pax6 example during eye formation. These results
suggest that elucidation of Lhx2  function in various
organs would give further insights into Lhx2 function in
the DoxHPC lines and hence both physiological and
pathological processes regulating normal HSCs. Con-
versely, elucidation of Lhx2 function in DoxHPC would
give insights into Lhx2 function in various basic processes
during embryonic development, such as mesenchymal-
epithelial interactions and regulation of stem/progenitor
cells in non-hematopoietic tissues. We are at present time
exploring all alternatives of Lhx2  function presented
above.
Conclusion
Expression of the LIM-homeobox gene Lhx2 in hemat-
opoietic cells derived from both ES cells differentiated in
vitro and from bone marrow, allows for the generation of
HSC-like cell lines. To address the molecular basis of Lhx2
function, we have analysed global gene expression in
HSC-like cell lines with inducible Lhx2 expression. This
approach identified 267 differentially expressed genes
where 141 (144 Unigene clusters) were down-regulated
and 126 (131 Unigene clusters) were up-regulated when
Lhx2 expression was turned off. The relevance of this
model system for normal HSC function was revealed by
that the majority of the differentially expressed genes
overlapping with HSC-specific datasets were defined as
stem cell-specific in our system, and the majority of the
differentially expressed genes overlapping with more dif-
ferentiated hematopoietic cell population were defined as
differentiation- or commitment-specific in our system.
Moreover, gene expression analyses in various tissues dur-
ing embryonic development of the down-regulated genes
revealed that almost half of these genes showed overlap-
ping expression patterns with Lhx2, suggesting a func-
tional link to the development and regulation of various
tissues and stem/progenitor cells. Thus, this approach has
identified genes putatively linked to self-renewal / differ-
entiation of HSCs, and function of Lhx2 in organ develop-
ment and stem / progenitor cells of non-hematopoietic
origin.BMC Genomics 2006, 7:75 http://www.biomedcentral.com/1471-2164/7/75
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Methods
Generation of ES cells with inducible Lhx2 expression
The ES cell line Ainv15 was maintained on irradiated
mouse embryonic feeder (MEF) cells in Dulbecco's modi-
fied Eagle medium (DMEM) (Gibco-BRL, United King-
dom) supplemented with 15% fetal calf serum (FCS)
(Boehringer, Germany), 1.5 × 10-4 M monothioglycerol
(MTG) (Sigma, Germany) and leukaemia inhibitory fac-
tor (LIF) (Chemicon, Ca, USA). Lhx2 cDNA or Lhx2 cDNA
linked to a green fluorescent protein cDNA preceded by
an internal ribosomal entry site (Lhx2-ires-GFP), was
inserted into the plox vector and transfected into the
Ainv15 ES cells together with Cre recombinase cDNA as
previously described [22], and subsequently cultured in
200 µg/ml G418 (Gibco-BRL). Clones of ES cells resistant
to G418 were isolated, pooled and expanded.
Differentiation of ES cell in vitro
ES cells used for in vitro differentiation were made feeder-
independent in serum-free medium as previously
described [60,61]. Briefly, ES cells cultured on MEF cells
were trypsinized and transferred to gelatinized culture
flasks in N2B27 medium (Gibco-BRL) supplemented with
104 U/ml LIF and 10 ng/ml BMP4 (R&D-systems, United
Kingdom). The ES cells were trypsinized and transferred
into Iscove's modified Dulbecco's media (IMDM) (Gibco-
BRL) supplemented with 15% FCS (Integro Inc., The
Netherlands), 4.5 × 10-4 M MTG and 25 µg/ml ascorbic
acid (Sigma) at 103 cells/ml. Embryoid bodies (EBs) were
collected after five days of differentiation, resuspended in
trypsin-EDTA and incubated for three minutes. Two ml of
FCS was added and the cells were gently passaged through
a syringe with a 20-gauge needle. Ten ml of IMDM
medium was added; the cells were spun down and resus-
pended in fresh IMDM medium.
Progenitor (clonal) assays of EB cells
The progenitor assays were carried out in IMDM contain-
ing 1% methylcellulose (Fluka, Switzerland) and supple-
mented with L-glutamine, 300 g/ml iron-saturated
transferrin (Boehringer), 5% protein-free hybridoma
medium II (Gibco-BRL), 10% plasma-derived serum
(Antech Inc., Tx, USA), 100 ng/ml murine Steel factor (SF)
R&D-systems), 10 ng/ml human IL-6 (R&D-systems), 4
IU/ml erythropoietin (Eprex Janssen-Cilag, Sweden) and
with or without 2 µg/ml doxycyclin (dox) (Sigma). 105 or
2 × 105 EB cells were plated in triplicates in a final volume
of 1.25 ml in 35-mm Petri dishes (Falcon 1008). Primitive
erythroid colonies were scored after 4–6 days of incuba-
tion and definitive hematopoietic colonies (e.g. SF/IL-6-
responsive) were scored after 10–12 days of incubation.
Generation and maintenance of DoxHPC lines with Lhx2 
expression regulated by the tet-on system
Individual colonies were randomly picked from the clonal
assays after 12 days of incubation, transferred to 96-well
plates and expanded in IMDM supplemented with 5%
FCS, 1.5 × 10-4 M MTG, 100 ng/ml SF, 10 ng/ml IL-6 and
2 µg/ml dox. Stable cell lines could be established from all
cultures containing cells with blast-like morphology after
three weeks in liquid culture. These cell lines were subse-
quently maintained in this media at cell densities between
5 × 105 and 2 × 106 cells/ml as previously described [20].
The efficiency of the system was verified by removing dox
and analysing Lhx2 transcription by real-time PCR or GFP
expression by flow cytometry at different time points after
dox withdrawal (Figure 1A and 1B). No cell lines could be
established from the control cell line expressing GFP
alone or from colonies expanded in the absence of dox, as
such cells differentiated into mast cells under these culture
conditions. Two cell lines called DoxHPC1 and DoxHPC7
were selected for further gene expression analysis. The
DoxHPC7 line was established from the ES cells where
GFP was linked to Lhx2 expression.
Design of the microarray experiment
The gene expression changes in DoxHPC1 and DoxHPC7
cell lines were analysed using the hybridization scheme in
Figure 2A. Total RNA prepared from Lhx2 expressing cells
was used as reference and compared to total RNA pre-
pared from three time-points (36, 72 and 96 hours) after
dox withdrawal. Two independent cell cultures were car-
ried out for both DoxHPC1 and DoxHPC7 lines, provid-
ing a first level of replication. Each comparison was
further analysed using two replicated hybridizations with
the dye assignments reversed, providing a second level of
replication. Finally, each probe was printed in duplicate
on the arrays, which for each comparison results in eight
measurements using three different levels of replication.
Additional hybridizations carried out included replicated
comparisons between the two separate cultures of each
cell line, and a direct replicated comparison between
Lhx2-expressing DoxHPC1 and DoxHPC7 cell lines.
The cDNA microarray
The cDNA arrays were produced at the KTH Microarray
Center and contain 14,121 in-house sequenced cDNA
clones originating from a mouse brain lateral ventricle
wall library, a normalized neurosphere library, an adult
bone-marrow derived hematopoietic stem cell line
expressing Lhx2 and additional control features including
the Lucidea Universal ScoreCard probes (Amersham Bio-
sciences, Sweden). A detailed description of the libraries is
available elsewhere [62]. Details regarding the probes and
cDNA amplification, purification and printing are availa-
ble through the ArrayExpress microarray data repository
using the array accession number A-MEXP-175. In brief,BMC Genomics 2006, 7:75 http://www.biomedcentral.com/1471-2164/7/75
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the cDNA inserts were amplified using Platinum Taq DNA
polymerase (Invitrogen, Sweden), purified using the Mul-
tiscreen-PCR 384-well plates (Millipore, Sweden) auto-
mated on the Biorobot 8000 platform (Qiagen, Germany)
and printed in either 30 or 50% DMSO. Probes were
printed with a feature-to-feature distance of 175 µm into
two identical fields consisting of 24 blocks each. The
printed DNA was attached to the reactive surface of the
Ultra-GAPS slides (Corning B.V., The Netherlands) using
250 mJ/cm2 UV light. All cDNA sequences on the chip are
deposited in the dbEST sequence database [63] and are
accessible with the GenBank accession numbers listed in
the ArrayExpress database. All clone annotations are
derived from Mus musculus UniGene build 144, unless
otherwise stated.
Target preparation
Total RNA extraction from eight DoxHPC1 and eight
DoxHPC7 samples was carried out using the RNeasy tech-
nology (Qiagen) and quality and quantity determined
using the RNA Nano LabChip kit on the Agilent 2100 bio-
analyzer (Agilent Technologies, Ca, USA) and Nanodrop
ND-1000 spectrophotometer (Nanodrop Technologies,
De, USA), respectively. For each cDNA synthesis reaction
20 µg of total RNA was mixed with 5 µg of random hex-
amer primer (Invitrogen), incubated at 70°C for 10 min-
utes, and finally on ice for at least 5 minutes. Reverse-
transcription reaction mixture and 400 units of Super-
script II RT-polymerase were added to yield a final volume
of 30 µl containing first-strand buffer (Invitrogen), 10
mM DDT (Invitrogen) and 0.5 mM dNTPs (Sigma). The
ratio of aminoallyl-modified dUTP to dTTP was 4:1 in the
dNTP mixture. The reaction was carried out at 42°C for
two hours, followed by 15 minutes hydrolysis of the RNA
strand at 70°C in the presence of 16 mM EDTA (Sigma)
and 150 mM NaOH. The reaction was neutralized using
150 mM HCl and purified using the MinElute Reaction
Cleanup system (Qiagen) with the provided wash and
elution buffers replaced by 80% ethanol and 100 mM
NaHCO3, pH 9.0, respectively. A repeated elution from
the column was carried out, generating a total volume of
20 µl. This was transferred to an aliquot containing one
tenth of the monofunctional NHS-ester Cy3 or Cy5 dye
tubes (Amersham Biotech), which had been dissolved in
DMSO and subsequently dried in a vacuum centrifuge.
After a 30-minute incubation in darkness at room temper-
ature, the samples to be co-hybridized on a slide were
pooled and purified using the MinElute columns.
Microarray hybridization and signal extraction
To avoid unspecific hybridization to the surface the slides
were pre-hybridized for 30 minutes in a solution consist-
ing of 5xSSC, 0.1% SDS (Sigma) and 1% BSA (Sigma).
Slides were subsequently washed in water and isopropa-
nol (Sigma) and dried using a slide centrifuge. The
labeled, pooled and denatured (3 minutes at 95°C) sam-
ples in a hybridization mixture containing 25 µg mouse
Cot-1 DNA (Invitrogen), 40 µg poly-(dA) DNA
(Operon),25% formamide (Sigma), 5xSSC and 0.1% SDS
were applied under a LifterSlip cover (Erie Scientific Com-
pany, Nh, USA) and hybridized for 16–20 hours at 42°C
in a water bath. After hybridisation the slides were washed
with increasing stringency using 2xSSC and 0.1% SDS at
42°C, followed by 0.1xSSC and 0.1% SDS at room tem-
perature and finally five times with 0.1xSSC at room tem-
perature. Scanning was carried out at 10-µm resolution
using the G2565BA DNA microarray scanner (Agilent
Technologies) for which the photo multiplier tube was set
to 100. The obtained TIFF-images were analysed using the
GenePix Pro 5.1 software (Axon Instruments, Ca, USA).
For each slide the foreground and background signal
intensities were separated using the irregular feature-find-
ing algorithm implemented in the software. A manual
inspection was carried out to verify the results. The raw
data, including several quality parameters, is available
from the ArrayExpress data repository using the experi-
ment accession number E-MEXP-431.
Microarray data analysis
Data processing and identification of differentially
expressed genes was carried out in the R environment for
statistical computing and programming [64] using the
Bioconductor package bundle [65], Limma [66], aroma
package [67] and the kth-package [68]. As a first step the
Cy3 and Cy5 intensities without background subtraction
were converted to M (=log2 [red channel/green channel])
and A (=log2  [red channel*green channel]/2) format
using the median intensity values for both channels. A
feature was considered unreliable and removed from fur-
ther analysis if GenePix flagged it as "Not Found" or if it
was manually flagged as "Bad"during the image analysis
step. Furthermore, if a feature satisfied one of the follow-
ing criteria it was considered unreliable: a) both channels
were saturated (above 65190 intensity units), b) the per-
centage of foreground pixels above the local background
plus two of its standard deviations were below 70 for both
channels of a feature, or c) the signal-to-noise ratio
(defined as [mean foreground-mean background]/back-
ground standard deviation) for both channels was below
3. Remaining data was normalized using the intensity-
dependent print-tip lowess method [69] and differentially
expressed genes identified using the empirical Bayes mod-
erated t-test implemented in the Limma package. As a first
step the signal intensities for duplicate features on each
array were averaged. Replicated hybridizations are
expected to have a higher correlation than the repeated
cell cultures for each cell line. This was considered in the
linear model by first estimating the between-replicates
correlation by using restricted maximum likelihood
methods to estimate a common correlation for all probesBMC Genomics 2006, 7:75 http://www.biomedcentral.com/1471-2164/7/75
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[70]. Secondly, a linear model was fit for each probe using
generalized least squares that takes into account the
between-replicates correlation. In the third step an empir-
ical Bayes approach was used to shrink the gene-wise
standard errors towards a common value and a moder-
ated t-statistic was calculated [66,71]. To compensate for
multiple testing, the p-values associated with this t-statis-
tics were adjusted using a false-discovery rate approach
[72] implemented in R. Finally, probabilities for differen-
tial expression (B-values) were calculated for each gene.
For these calculations the a priori assumption of differen-
tially expressed genes was set to 0.01.
Classification into Gene Ontology functional groups [27]
and analysis of over-represented themes was carried out
using the EASE-package available at [73,74]. The complete
mouse transcriptome was used for calculation of the
expected frequencies in the over-representation analysis,
and a Gene Ontology theme (detail level 3) was consid-
ered over-represented if the calculated EASE score was
below 0.1.
Analysis of differentially expressed genes by real-time PCR
Total RNA was extracted from cell pellets with TRizol rea-
gent (Invitrogen). cDNA was synthesized by using the
First-strand cDNA synthesis kit (Amersham Biosciences).
Real-time PCR reactions were carried out in triplicates
using SYBR green PCR master mix (Applied Biosystems,
Ca, USA) and PCR products were detected with an ABI
prism 7000 instrument (Applied Biosystems). The expres-
sion levels of the genes tested were normalized to the
expression levels of Gapdh and confirmed with two addi-
tional housekeeping genes: Hprt1 (hypoxanthine phos-
phoribosyltransferase 1) and Tbp (TATA box binding
protein) (data not shown). The following primers were
used in the PCR analyses: Lhx2 Forward (F)- GCC GAG
AAA GCG CAA GAG T and Reverse (R)- TGT TCA GCA
TCG TTC TCG TTA CA; Plscr1 F- AGC TGC TGT TCC GAC
ATT GA and R- GGA ACT GGA TCC CAA AAT TGT CT;
Bpgm F- CTT AAA GGG CAA AAG CAT TCT GAT and R-
TGG GCA GAG TGA TGT TGA TAA TAT C; Galnt2 F- TGC
GGG TCC TCA GAA ATG A and R- TCA GCA ACC CGC
TCC AA; Serpina3g F- CCT ACA GAT CCT GGC AGA GTT
CA and R- GAT CTT CCC CTG GGT GTG ATT; Syne2 F-
GGA GGT GTT CGG CAG AGT GT and R- TCT TCT ATG
TCC GTC TCA TTC TCA GA; Csrp2 F- CCG TGT ATG CTG
CGG AGA A and R- TTG GCA CAC CGG AAA CAG T;
Upp1 F-TGA CCG CTA CGC CAT GTA TAA A and R- CAT
GAT GCC GAT GGA AGG A; MyoIb F- ATC AGG TCA
AGG AAC AGC TTC TG and R- TCA TTC CTC ACA GTC
TTG GCA TT; Etv5 F- GAG CCG CTC TCT CCG CTA T and
R- CCG GGT CAC ACA CAA ATT TG; Perp F- CTT GTT TTC
CTG AGA GTC ATT GGA and R- GGT TAT CGT GAA GCC
TGA AGG T; 2610034M16Rik F- GAG GAC TCA CTC AGG
TTT TGT GAA and R- AAT GTC AAC TTC TGC TCC TTC
TAA TTT TA; Ncf1 F- CAA AGA TGG CAA GAA TAA CGT
AGC T and R- AGT CAG CAA TGG CCC GAT AG; Slc2a3
F- ACG ATC GGC TCT TTC CAG TTT and R- TTC TAA CCG
CTC TTC CAA AGT GTA; Aldoa F-CCC TTC CCC CAA GTT
ATC AAG and R- GGC ACC ACA CCC TTA TCT ACC T;
Bnip3 F- GGT TTT CCT TCC ATC TCT GTT ACT GT and R-
GTT GTC AGA CGC CTT CCA ATG; Tpi1 F- ACC GAG
AAG GTC GTG TTC GA and R- GGC CAG GAC CAC CTT
GCT; Ndrg1 F- CAT CGG CAT GAA CCA CAA GA and R-
AAA ATG TTG TGT GAT CTC CTG CAT; Pgk1 F- GGA AGC
GGG TCG TGA TGA and R- GCC TTG ATC CTT TGG TTG
TTT G; Eno1 F- GGC ACC CTC TTT CCT TGC TT and R-
GGC GTG GAT CCT GAG AAT AGA C; Gapdh F- CGT GTT
CCT ACC CCC AAT GT and R- TGT CAT CAT ACT TGG
CAG GTT TCT; Hprt F- GCA GTA CAG CCC CAA AAT GG
and R- AAC AAA GTC TGG CCT GTA TCC AA; Tbp F- GAA
TTG TAC CGC AGC TTC AAA A and R- AGT GCA ATG
GTC TTT AGG TCA AGT T.
In situ hybridizations
Embryos were fixed in 4% paraformaldehyde, cryopro-
tected (30% sucrose in PBS), and embedded in Tissue-Tek
OCT compound and cryosectioned (8 µm). In situ hybrid-
ization using digoxygenin (Dig)-labeled probes was per-
formed as described [75], with some modifications.
Briefly, sections from E13.5 embryos were treated with 5
µg/ml proteinase K (Roche) in 0.1 M PBS for 15 minutes
at room temperature prior to hybridization. The DIG sig-
nal was visualized with NBT/BCIP (Roche). The following
probes were used: Lhx2 ([GenBank:NM_010710], probe
spanning the region 460–1750), Nuak1  ([Gen-
Bank:NM_001004363], 2382–3143), Tmem2  ([Gen-
Bank:BC076570], 296–1262), Enc1
([GenBank:NM_007930] 920–1793), and Etv5 ([Gen-
Bank:NM_023794], 661–1609).
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